Stories similar to New Clinical Trial for Multiple Myeloma:

Multiple Myeloma Cancer 1 year 8 weeks ago

Multiple myeloma is a plasma cell malignancy characterized by accumulation of plasma cells to long life in the bone marrow, the presence of significant levels of monoclonal immunoglobulin (IgA or IgG) in serum and urine of patients and generates characteristic bone lesions and alterations of hematopoietic and renal functions. Despite encouraging progress in treatment, multiple myeloma remains an incurable disease. This type of tumor patients reached an average of 65 years and is responsible for 2% of cancer mortality but 20% hematologic malignancies.

multiple myeloma 2011 1 year 14 weeks ago

Multiple myeloma (from Greek myelo-, bone marrow), also known as plasma cell myeloma or Kahler's disease (after Otto Kahler), is a cancer of plasma cells, a type of white blood ...multiple myeloma n. A malignant proliferation of plasma cells in bone marrow causing numerous tumors and characterized by the presence of abnormalMultiple myeloma

Hope on the Horizon for Pancreatic Cancer Patients 50 weeks 3 days ago

Milind Javle, M.D., associate professor in the Department of Gastrointestinal Medical Oncology at MD Anderson Cancer Center, is offering hope for those faced with pancreatic cancer.
Javle is leading a new clinical trial which targets the rapid growth of pancreatic cancer cells. This trial is testing the standard treatment with a new antibody that has shown promising results in the laboratory.

Skin Neoplasms Global Clinical Trials Review 1 year 15 weeks ago

“Skin Neoplasms Global Clinical Trials Review, Q1, 2011" provides data on the Skin Neoplasms clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Skin Neoplasms. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations.

Epidermolysis Bullosa Global Clinical Trials Review 1 year 15 weeks ago

“Epidermolysis Bullosa Global Clinical Trials Review, Q1, 2011" provides data on the Epidermolysis Bullosa clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Epidermolysis Bullosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations.